66 results
8-K
EX-99.1
UBX
Unity Biotechnology Inc
15 Apr 24
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
7:00am
here.
Recent and Upcoming Milestones
In January, the Company published new research in Nature Medicine, "Therapeutics targeting of cellular senescence
8-K
EX-99.1
at1 e8vr0h12k
1 Nov 22
UNITY Biotechnology Announces Positive 24-Week Data from Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema
7:00am
8-K
xdzmjrcf92f1clz nvv
19 Oct 22
Material Modifications to Rights of Security Holders
5:06pm
8-K
EX-99.1
ydhwlfbre ajsfh
19 Oct 22
Material Modifications to Rights of Security Holders
5:06pm
8-K
EX-1.1
lkta 5862
22 Aug 22
UNITY Biotechnology Announces Pricing of Upsized Underwritten Public Offering
4:13pm
8-K
EX-99.1
9hs58e6
22 Aug 22
UNITY Biotechnology Announces Pricing of Upsized Underwritten Public Offering
4:13pm
8-K
EX-99.1
y5u5lz7l7tmb
12 Aug 22
UNITY Biotechnology Announces Positive Data in Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema
7:18am